Jennifer Burstein insider trades: Loxo Oncology (LOXO) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jennifer reports to the SEC
Open-market buys and sales
17 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 11, 2018 | LOXO | ↓ Sell | 2,500 | $135.55 | $339K | Direct | Dec 12, 2018 (1d) |
| Nov 27, 2018 | LOXO | ↓ Sell | 2,500 | $147.68 | $369K | Direct | Nov 28, 2018 (1d) |
| Oct 4, 2018 | LOXO | ↓ Sell10b5-1 | 2,500 | $164.92 | $412K | Direct | Oct 5, 2018 (1d) |
| Sep 13, 2018 | LOXO | ↓ Sell | 2,500 | $166.96 | $417K | Direct | Sep 14, 2018 (1d) |
| Aug 14, 2018 | LOXO | ↓ Sell | 2,500 | $159.24 | $398K | Direct | Aug 15, 2018 (1d) |
| Jul 9, 2018 | LOXO | ↓ Sell | 1,500 | $187.25 | $281K | Direct | Jul 11, 2018 (2d) |
| Jun 19, 2018 | LOXO | ↓ Sell | 1,700 | $176.99 | $301K | Direct | Jun 21, 2018 (2d) |
| May 14, 2018 | LOXO | ↓ Sell | 1,700 | $136.93 | $233K | Direct | May 16, 2018 (2d) |
| Apr 24, 2018 | LOXO | ↓ Sell | 1,700 | $131.65 | $224K | Direct | Apr 26, 2018 (2d) |
| Mar 13, 2018 | LOXO | ↓ Sell | 1,700 | $131.33 | $223K | Direct | Mar 15, 2018 (2d) |
| Feb 12, 2018 | LOXO | ↓ Sell | 1,700 | $93.24 | $159K | Direct | Feb 14, 2018 (2d) |
| Jan 16, 2018 | LOXO | ↓ Sell | 1,500 | $87.50 | $131K | Direct | Jan 18, 2018 (2d) |
| Dec 14, 2017 | LOXO | ↓ Sell | 1,700 | $83.27 | $142K | Direct | Dec 18, 2017 (4d) |
| Nov 27, 2017 | LOXO | ↓ Sell | 1,700 | $74.82 | $127K | Direct | Nov 29, 2017 (2d) |
| Oct 30, 2017 | LOXO | ↓ Sell | 1,700 | $87.19 | $148K | Direct | Nov 1, 2017 (2d) |
| Sep 18, 2017 | LOXO | ↓ Sell | 1,700 | $89.10 | $151K | Direct | Sep 20, 2017 (2d) |
| Aug 14, 2017 | LOXO | ↓ Sell | 1,700 | $73.73 | $125K | Direct | Aug 16, 2017 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Jennifer Burstein's insider trades
Jennifer Burstein is Senior VP of Finance at Loxo Oncology (LOXO). Since Aug 14, 2017, Jennifer has reported no open-market purchases and 17 sales worth $4.2M on SEC Form 4. There have been no open-market trades in the last 12 months.
1 sale (10% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.
Their filings also include option exercises (17 filings), grants and awards (13 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every LOXO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.